HUTCHMED (LON:HCM) Share Price Passes Below Two Hundred Day Moving Average – Here’s Why

HUTCHMED (China) Limited (LON:HCM)’s stock price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 289.99 ($3.65) and traded as low as GBX 261 ($3.29). HUTCHMED shares last traded at GBX 264 ($3.33), with a volume of 39,973 shares traded.

HUTCHMED Trading Down 0.4 %

The company has a quick ratio of 2.97, a current ratio of 2.81 and a debt-to-equity ratio of 11.78. The company has a market cap of £2.26 billion, a price-to-earnings ratio of -6,600.00 and a beta of 0.76. The firm has a 50 day moving average price of GBX 284.72 and a two-hundred day moving average price of GBX 289.99.

HUTCHMED Company Profile

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in Hong Kong and internationally. The company develops Savolitinib for the treatment of non-small cell lung cancer (NSCLC), papillary renal cell carcinoma (RCC), and gastric cancer (GC); and Fruquintinib, an inhibitor for colorectal cancer (CRC), breast cancer, gastric cancer, microsatellite stable-CRC endometrial cancer (EMC), NSCLC, RCC, gastrointestinal, cervical, and solid tumors.